Development of Monoclonal Antibody-Based EIA for Tetranor-PGDM which Reflects PGD₂ Production in the Body

Table 1

Precision of the proposed EIA for tetranor-PGDM measurement at different concentration levels.

Concentration (ng/mL)					Mean recoveries (%)
Spiked	Mean		SD	CV (%)
Within-run ()
1.024	1.14	±	0.07	6.0	111.7
2.56	2.29	±	0.11	4.8	89.4
6.4	6.19	±	0.24	3.9	96.6
Between-day ()
1.024	1.10	±	0.11	10.4	107.6
2.56	2.45	±	0.14	5.7	95.5
6.4	6.25	±	0.41	6.6	97.7